RHN-001

N/A

Report date: 2024/08/14 09:00:18
NME

Base Information

Drug NameRHN-001
Drug Alias NameRHN-001RHN001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPakistan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRH Nanopharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesRH Nanopharmaceuticals LLC
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A